BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer

Clinical trial NCT03083691 · COMPLETED

Trial details

NCT number: NCT03083691
Sponsor: Lung Cancer Group Cologne
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Carcinoma, Small Cell Lung

Start date: 2017-04-13
Primary completion: 2022-08-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.